Gear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key Metrics

Core Viewpoint - Alcon (ALC) is expected to report quarterly earnings of $0.79 per share, a 9.7% increase year-over-year, with revenues projected at $2.71 billion, reflecting a 9.3% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate for the quarter has been revised upward by 1.5% over the past 30 days, indicating analysts' reappraisal of their initial projections [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Key Metrics Projections - Analysts project 'Net Sales- Total Surgical- Equipment/other' to be $277.54 million, a 21.2% increase from the prior-year quarter [5]. - 'Net Sales- Total Surgical- Implantables' is expected to reach $482.10 million, indicating a 5.7% year-over-year change [5]. - The estimate for 'Net Sales- Total Surgical' is $1.56 billion, reflecting a 9.3% increase year-over-year [5]. - 'Net Sales- Total Vision care' is projected at $1.15 billion, a 9.1% increase from the previous year [6]. - 'Net Sales- Total Surgical- Consumables' is expected to be $796.13 million, indicating a 7.9% year-over-year change [6]. - The consensus for 'Net Sales- Total Vision Care- Contact lenses' stands at $687.14 million, reflecting a 7.7% increase [6]. - 'Net Sales- Total Vision Care- Ocular health' is projected to reach $462.70 million, a change of 11.2% from the prior-year quarter [7]. - 'Net Sales and other revenues- Other revenues' is estimated at $26.18 million, suggesting a 4.7% year-over-year change [7]. Stock Performance - Over the past month, Alcon shares have returned +0.8%, while the Zacks S&P 500 composite has changed by -0.8% [7]. - Alcon holds a Zacks Rank 3 (Hold), indicating that its performance is expected to align with the overall market in the upcoming period [7].